US 10307418
Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
granted A61KA61K31/496A61K47/10
Quick answer
US patent 10307418 (Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds) held by Platform Brightworks Two, Ltd. expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Platform Brightworks Two, Ltd.
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/496, A61K47/10, A61K9/0019, A61K9/0053